Oxaliplatine Teva

Oxaliplatin, the active ingredient in Oxaliplatine Teva, is a platinum‑based chemotherapy presented as a sterile powder for intravenous infusion use. It is employed in the treatment of colorectal cancer and other gastrointestinal malignancies in adult patients. GNH USA supplies Oxaliplatine Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

GNH USA supplies Oxaliplatine Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

Oxaliplatin is a platinum‑based chemotherapeutic agent used in the management of cancers that arise from the gastrointestinal tract.

- Colorectal cancer: improves the overall treatment outcome by reducing tumor size and progression. - Gastric cancer: used in combination regimens to shrink tumors and enhance surgical options. - Pancreatic but    --- -  ...